Athanassios Argiris Selected Research

Athanassios Argiris Research Topics

Disease

43	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 05/2002
42	Neoplasms (Cancer) 03/2022 - 11/2002
33	Squamous Cell Carcinoma of Head and Neck 03/2022 - 07/2006
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 03/2004
10	Disease Progression 01/2022 - 12/2003
7	Lung Neoplasms (Lung Cancer) 01/2021 - 06/2004
5	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2003
4	Neutropenia 12/2019 - 08/2004
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2011 - 02/2004
3	Fatigue 12/2020 - 12/2010
3	Thrombocytopenia (Thrombopenia) 12/2019 - 08/2004
3	Diarrhea 04/2013 - 03/2004
3	Mucositis 01/2010 - 08/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2008 - 05/2005
2	Pain (Aches) 12/2020 - 01/2017
2	Hyponatremia 12/2019 - 12/2016
2	Headache (Headaches) 12/2016 - 08/2012
2	Anemia 12/2016 - 12/2003
2	Complementation Group E Xeroderma Pigmentosum 10/2011 - 12/2010
2	Colorectal Neoplasms (Colorectal Cancer) 02/2010 - 08/2004
2	Carcinoma (Carcinomatosis) 07/2007 - 11/2004
1	Necrosis 01/2022
1	Nasopharyngeal Carcinoma 01/2022
1	Residual Neoplasm 01/2022
1	Hemorrhage 12/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2019
1	Febrile Neutropenia 12/2019
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2019
1	Edema (Dropsy) 12/2016
1	Oropharyngeal Neoplasms 01/2016

Drug/Important Bio-Agent (IBA)

15	ErbB Receptors (EGF Receptor)IBA 10/2018 - 03/2004
13	Cetuximab (Erbitux)FDA Link 10/2018 - 07/2007
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2006
9	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2017 - 06/2004
9	Docetaxel (Taxotere)FDA Link 11/2015 - 11/2002
9	Cisplatin (Platino)FDA LinkGeneric 10/2014 - 11/2002
7	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 05/2004
7	Tyrosine Kinase InhibitorsIBA 04/2013 - 03/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 10/2009
5	Bevacizumab (Avastin)FDA Link 01/2020 - 02/2010
5	Gefitinib (Iressa)FDA Link 04/2013 - 03/2004
5	Proteins (Proteins, Gene)FDA Link 04/2012 - 06/2004
4	Monoclonal AntibodiesIBA 12/2019 - 07/2007
4	PlatinumIBA 12/2019 - 08/2011
4	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 03/2008
4	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 05/2004
4	Irinotecan (Camptosar)FDA LinkGeneric 07/2013 - 11/2002
4	Bortezomib (Velcade)FDA Link 07/2013 - 01/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2011
3	LigandsIBA 01/2019 - 02/2010
3	Pemetrexed (MTA)FDA Link 06/2013 - 08/2004
3	Epidermal Growth Factor (EGF)IBA 11/2012 - 06/2004
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2011 - 12/2003
3	Hydroxyurea (Hydrea)FDA LinkGeneric 08/2004 - 01/2003
2	Tadalafil (Cialis)FDA Link 03/2022 - 01/2020
2	NivolumabIBA 03/2022 - 01/2020
2	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2019
2	Programmed Cell Death 1 ReceptorIBA 06/2021 - 01/2019
2	veliparibIBA 01/2021 - 12/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 12/2019
2	Antisense DNAIBA 10/2018 - 03/2009
2	Everolimus FDA Link 12/2016 - 12/2010
2	Pharmaceutical PreparationsIBA 12/2016 - 05/2016
2	TOR Serine-Threonine KinasesIBA 12/2016 - 12/2010
2	Sulindac (Copal)FDA LinkGeneric 06/2014 - 11/2012
2	Proteasome InhibitorsIBA 07/2013 - 01/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2009 - 04/2008
2	Celecoxib (Celebrex)FDA Link 04/2008 - 05/2006
2	Gemcitabine FDA Link 03/2005 - 08/2004
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	apatinibIBA 01/2022
1	thiamine triphosphorate (TTP)IBA 12/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2019
1	Cytotoxins (Cytolysins)IBA 12/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2017
1	rilotumumabIBA 08/2017
1	CrizotinibIBA 01/2017
1	PerforinIBA 01/2017
1	Granzymes (Granzyme)IBA 01/2017
1	human ALK1-Fc fusion proteinIBA 12/2016
1	Activin Receptors (Activin Receptor)IBA 12/2016
1	AntibodiesIBA 01/2016
1	Protein Subunit VaccinesIBA 05/2014
1	VaccinesIBA 05/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2014
1	Etoposide (VP 16)FDA LinkGeneric 10/2013
1	Histone Deacetylase InhibitorsIBA 10/2013
1	PanobinostatIBA 10/2013

Therapy/Procedure

28	Therapeutics 02/2022 - 05/2002
24	Drug Therapy (Chemotherapy) 01/2021 - 05/2002
21	Radiotherapy 01/2022 - 01/2003
10	Chemoradiotherapy 01/2021 - 05/2002
6	Immunotherapy 02/2022 - 01/2017
6	Induction Chemotherapy 10/2013 - 12/2003
3	Neck Dissection (Radical Neck Dissection) 12/2007 - 05/2004
2	Combined Modality Therapy 01/2021 - 05/2004
1	Laryngectomy 01/2019
1	Injections 10/2018